Direct infrared analysis of post-translational modification of proteins

Patent metadata

Field	Value
Publication number	US-12029552-B2
Application number	US-201716082113-A
Country	US
Kind code	B2
Filing date	Mar 6, 2017
Priority date	Mar 6, 2016
Publication date	Jul 9, 2024
Grant date	Jul 9, 2024

Abstract

A method and system are provided for measuring post-translational modification of proteins in a subject. The method comprises recording of infrared radiation within a predetermined wavenumber range and attenuated by an integument of the subject, such that the integument is still attached to the subject. The method further comprises the step of comparing the attenuation of infrared radiation to a predetermined value for deriving information regarding post-translational modification of proteins in the integument.

First claim

The invention claimed is:

1. A method for measuring post-translational modification of proteins in a subject, the method comprising:
measuring and recording of infrared radiation within a predetermined wavenumber range on a nail plate of the subject, wherein said nail plate is still attached to said subject, the infrared radiation being attenuated by nail plate protein glycation in the nail plate;
comparing said attenuation of infrared radiation to a predetermined value for deriving information regarding post-translational modification of proteins in the nail plate;
wherein said comparing comprises comparing a contribution of different spectral bands within a range of 4000 cm −1 to 4500 cm −1 ; and
deriving a degree of glycemia in the subject based on said comparison of the contribution of different spectral bands within the range of 4000 cm −1 to 4500 cm −1 ,
wherein said attenuation of infrared radiation comprises attenuation by post-translational modified integument protein in said nail, said protein being a keratin.

2. The method according to claim 1 , wherein the method comprises performing any of near infrared spectroscopy, Fourier transform infrared spectroscopy or infrared reflection spectroscopy.

3. The method according to claim 1 , wherein the method comprises recording attenuation of infrared radiation at different positions on the nail plate, comparing said attenuation of infrared radiation at different positions to a predetermined value and deriving based thereon a time dependency of the post-translational modification of proteins.

4. The method according to claim 1 , wherein the method comprises selecting said predetermined value as function of race or gender of the subject.

5. A system for measuring post-translational modification of proteins in a subject, the system comprising an infrared radiation source, an infrared radiation detector and a data analyser for analysing attenuation of infrared radiation within a predetermined wavenumber range attenuated by a nail plate of said subject still attached to said subject, the infrared radiation being attenuated by nail plate protein glycation in the nail plate, by comparing the attenuation with a predetermined value for deriving information regarding post-translational modification of proteins in the nail plate;
wherein the analyser is configured to compare a contribution of different spectral bands within a range of 4000 cm −1 to 4500 cm −1 ; and
deriving a degree of glycemia in the subject based on said comparison of the contribution of different spectral bands within the range of 4000 cm −1 to 4500 cm −1 , and
wherein said system comprises a holder for positioning a finger or toe such that a nail of a subject is positioned with respect to said infrared radiation source and infrared radiation detector.

6. The system according to claim 5 , wherein the system is adapted for measuring at different positions on the nail plate of the subject.

7. The system according to claim 5 ,
wherein said post-translational modification of proteins consists of glycation of nail keratins, the data analyser being adapted for analysing attenuation of infrared radiation from within the wavenumber range of 400 to 5500 cm −1 .

8. A post-translation modified integument protein for use in in vivo diagnosis of anomalous post-translation modification of proteins comprising the method of claim 1 .

9. The post-translation modified integument protein according to claim 8 , the post-translation modified integument protein being a biological marker for said in vivo diagnosis of anomalous post-translation modification of proteins.

10. The post-translation modified integument protein according to claim 8 , the post-translation modified integument protein being a keratin or a glycated integument protein.

11. Use of the post-translation modified integument protein according to claim 8 for the in vivo diagnosis of a disease.

12. The use of the post-translation modified integument protein according to claim 11 , wherein the post-translation modified integument protein is a glycated protein and wherein said in vivo diagnosis comprises the diagnosis of diabetes mellitus.

13. A method for measuring post-translational modification of proteins in a subject, the method comprising:
measuring and recording of infrared radiation within a predetermined wavenumber range on a nail plate of the subject, wherein said nail plate is still attached to said subject, the infrared radiation being attenuated by nail plate protein glycation in the nail plate;
comparing said attenuation of infrared radiation to a predetermined value for deriving information regarding post-translational modification of proteins in the nail plate;
wherein said comparing comprises comparing a contribution of different spectral bands within a range of 4000 cm −1 to 4500 cm −1 ; and
deriving a degree of glycemia in the subject based on said comparison of the contribution of different spectral bands within the range of 4000 cm −1 to 4500 cm −1 .

Assignees

• Univ Gent

Inventors

• Delanghe Joris
• Speeckaert Marijn
• Monteyne Tinne
• De Beer Thomas

Classifications

• G01N21/35

  using infrared light (G01N21/39 takes precedence) · CPC title

• A61B5/4866

  Evaluating metabolism (using breath test A61B5/083) · CPC title

• A61B5/4848

  Monitoring or testing the effects of treatment, e.g. of medication · CPC title

• A61B5/4842

  Monitoring progression or stage of a disease · CPC title

• A61B5/0075

  by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy (A61B5/0071 takes precedence) · CPC title